Herbal remedies MenopauseRx.com - Making menopause manageable.
Women Logo Home Health Center Pharmacy Library Medical Professionals   About Us Contact Us Site Map

   
News
Reference
Articles
MenopauseRx.com eNewsletter Archive
Book Club
Events
Links
Menopause Study Results
Survey Information
Perimenopause and Menopause Survival Kit

Menopause Survival Kit

For only $3.49 sign up for the MenopauseRx Menopause and Perimenopause Survival Kit to receive free products, educational materials and coupons to relieve menopause symptoms including a full sized sample of a Remifemin® black cohosh supplement.

Order Now for Only the Cost of Shipping & Handling
  
Enter your e-mail here to sign up.


Archive

Posts Tagged ‘Osteoporosis’

Do calcium supplements increase the risk of heart disease?

August 11th, 2010 No comments

Recent media reports reviewed a study from New Zealand that concluded calcium supplements increase the risk of heart attacks among subjects.  To verify the link between calcium supplements and heart attacks, researchers at the University of Auckland studied the records of 12,000 people, both male and female, who had previously joined 11 separate clinical trials.   Participants (all over age 40) in this study from the British Medical Journal were given at least 500 mg of elemental calcium per day. The researchers concluded that calcium supplements increase the risk of myocardial infarction by about 30% over five years. 

This new study contradicts many previous studies that showed increased calcium intake did not affect cardiac health.  In fact, a study released in the July/August, 2010 Journal of the North American Menopause Society concluded that moderate doses of calcium plus vitamin D did not seem to alter the risk of future cardiovascular disease.  This study was part of the Women’s Health Initiative, and was a prospective study in which data was collected over seven years.  In contrast, the New Zealand study was meta-analysis type of study, which is considered an inferior type of study compared to a prospective study.  Read more…

New Osteoporosis Treatment Approved

June 6th, 2010 1 comment

Last week, Prolia™ (denosumab) was approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.  In postmenopausal women with osteoporosis, Prolia reduces the incidence of vertebral, non-vertebral and hip fractures.  

 Prolia is the first and only RANK ligand inhibitor approved by the FDA.  Prolia has a Risk Evaluation and Mitigation Strategy (REMS) that consists of a Medication Guide and a Dear Healthcare Professional Letter.  The manufacturer, Amgen, is also launching a voluntary program to monitor the long-term safety of Prolia and enhance the quality of data collected in the postmarketing setting.  This program is called the Prolia Post Marketing Active Safety Surveillance Program and is intended to collect information about pre-specified adverse events of special interest that may be reported by patients.  More information about this program may be found at www.proliasafety.com or by calling Amgen Medical Information at 1-800-772-6436.

 Prolia Important Safety Information 

Read more…

National Osteoporosis Awareness Month

May 18th, 2010 No comments

This month is National Osteoporosis Awareness and Prevention Month.  MenopauseRx would like to remind women that osteoporosis is especially prominent after the menopause transition.  Bone loss occurs during the perimenopause and after the menopause transition.  Unfortunately, the can lead to an increased risk of a serious fracture.  In fact, one out of every two women over the age of 50 will suffer from osteoporosis.  The goal of enhanced awareness is to reduce the widespread prevalence of osteoporosis and associated fractures and to find a cure for the disease through programs of awareness, education, advocacy and research.

Learn more at: http://www.menopauserx.com/health_center/health_Osteoporosis.htm

Calcium Intake Crucial to Benefits of Osteoporosis Drugs

May 5th, 2010 1 comment

PITTSBURGH – – Although an increasing number of people are taking powerful new prescription drugs to treat osteoporosis, chances are the majority of patients are not getting the greatest effect from these medicines because they do not have an adequate calcium and vitamin D intake, according to a paper published in the March 2005 issue of The Journal of Women’s Health. John A. Sunyecz, M.D., president of MenopauseRx, Inc., who co-authored the paper, “Calcium’s Role in Osteoporosis Drug Therapy,” notes that many people being treated for osteoporosis mistakenly think their calcium and vitamin D intake is no longer important once prescription therapy begins. “People taking osteoporosis medications should remember that they do not contain calcium and have been proven most effective when taken with adequate calcium and vitamin D, usually achieved with the addition of supplements to the daily diet,” he explains.

“This paper builds on previous research published last year that shows physicians are not taking the clinical information we know about these drugs and putting it into practice when treating patients. From 1994 to 2003 there was a five-fold increase in prescriptions for bisphosphonates, however during that same time period, the percentage of osteoporosis patients who were treated with calcium supplements decreased by nearly 50 percent.”

Read more…

Bone Up On Vitamin D

(NAPSI)-Weak, fragile bones and susceptibility to fractures-these are some of the painful consequences of the debilitating bone disease, osteoporosis. Currently, 10 million people suffer from osteoporosis in the United States and another 34 million are at risk of developing the disease. The Surgeon General has named osteoporosis a national health threat and estimated that by 2020 one in two Americans over the age of 50 will be at risk for fractures from osteoporosis or low bone mass.

There are several risk factors associated with the development of osteoporosis, including inadequate levels of vitamin D, a nutrient essential to the body’s absorption of calcium. Recent research has uncovered that over 70 percent of women over the age of 50 have low levels of vitamin D, and even women being treated for osteoporosis have low levels of the important vitamin. To address the need for greater awareness about low levels of vitamin D, Spirit of Women Hospital Network has teamed up with Dr. Marie Savard, an internationally recognized women’s health expert, to launch a new vitamin D risk assessment.
Read more…